Increase in adoption of intrathecal pump implants for treatment of chronic pain is projected to aid in intrathecal pumps market expansionRise in prevalence of chronic and acute diseases is expected
/PRNewswire/ The global intrathecal pumps market is projected to grow at a CAGR of 4.5% from 2022 to 2031. Chronic pain has now become more common in most.
The Intrathecal Pumps Market in China accounts for US$ 43.6 Mn by 2032. The market for morphine intrathecal pumps is projected to grow at a CAGR of 4.8%.
/PRNewswire/ DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute.